Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,555 across all filing types
Latest filing 2009-11-12 Regulatory Filings
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Daily Share Buy-Back Notice 2 pages ?Kb
Regulatory Filings
2009-11-12 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's share buy-back activity, including number of shares bought back, prices paid, and remaining shares to be bought back. It references compliance with Corporations Law and is a formal notice to the ASX (Australian Securities Exchange). The content is focused on reporting daily share repurchase activity rather than a full financial report or announcement of a report. This matches the description of a Transaction in Own Shares (POS) filing, which reports the company's buyback of its own shares. The document length is short and specific to buy-back details, not a broader financial or management report.
2009-11-11 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's share buy-back activity, including number of shares bought back, prices paid, and compliance statements. It is a regulatory form related to the company's repurchase of its own shares. This matches the description of 'Transaction in Own Shares' filings, which report the company buying back or selling its own shares. The document length is short and focused solely on buy-back details, not a full financial report or announcement of a report. Therefore, the correct classification is POS (Transaction in Own Shares).
2009-11-10 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and references ASX rules related to new securities issuance and quotation. It details the class, number, terms, and purpose of securities issued, including ordinary shares and options under employee plans. The document includes sections on quotation of securities and warranties to ASX. This is a standard form used in Australian securities markets to announce new share issues and apply for quotation of additional securities. It is not a financial report, earnings release, or management discussion, but a formal announcement of a capital change event. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is the announcement itself, not a brief notice or a report publication announcement.
2009-11-10 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's daily share buy-back activity, including number of shares bought back, prices paid, and compliance statements. It references ASX rules and is a formal notice of share repurchase activity. This matches the description of a 'Transaction in Own Shares' filing, which reports on the company's buy-back of its own shares. The document length is short and focused solely on buy-back details, not a broader financial report or announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2009-11-09 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's share buy-back activity, including number of shares bought back, prices paid, dates, and compliance statements. It is a regulatory form specifically related to the company's repurchase of its own shares. The content matches the description of a 'Transaction in Own Shares' filing, which reports on share repurchase activities. The document length is about 2505 characters, which is sufficient to contain substantive data rather than just an announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2009-11-08 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.